Respiratory Flashcards
(271 cards)
1
Q
1 kPa=
A
7.5 mmHg
2
Q
Dalton’s Law
A
gases in a mixture exert pressures that are independent of each other
Therefore: atmospheric pressure is the sum of the partial pressures of all of the gases in the atmosphere
Pat = PN2 + PO2 + PCO2 + PH2O + Pothers
3
Q
Henry’s Law
A
the concentration of the gas dissolved in a liquid is directly proportional to its partial pressure
4
Q
what is gas exchange in the lungs driven by?
A
differences in partial pressure across the alveolar membrane: inspired air has higher PO2 and a lower PCO2 than the plasma
5
Q
1 mol=
A
22400 ml of gas
6
Q
equilibrium in gas exchange in alveoli
A
- Gas exchange in the alveoli is so rapid that equilibrium is usually attained
- If equilibrium is not reached, usually due to V/Q ratio
7
Q
V/Q ratio
A
amount of air that reaches your alveoli divided by the amount of blood flow in the capillaries in your lungs
8
Q
passive diffusion through biological membranes
A
- Gases go through membranes by diffusion
- The rate of permeation is proportional to the concentration difference
- If concentrations are the same of each side of the membrane, there is no net movement (diffusion occurs at equal rates on each side)
9
Q
what is P (permeation constant) dependant on?
A
membrane thickness, membrane area, diffusion constant and the partition coefficient
10
Q
solubility of oxygen=
A
= 1.5% in free solution and rest is bound to haemoglobin
- Oxygen carrying capacity depends on the amount of haemoglobin
11
Q
haemoglobin: structure, cooperativity and conformational states
A
- Tetrameric protein
- 2 types of subunits adult = alpha2beta2 (and foetal= alpha2gamma2)
- Every molecule of Hb binds 4 O molecules
- As one oxygen molecule binds, each subunit undergoes a conformational change by non-covalent inter-subunit bonds which makes it easier for other oxygen molecules to bind
- 2 conformational states: oxy and deoxy- binding and release of O2 occurs over a relatively small range of oxygen concentrations
12
Q
why can foetuses take oxygen from maternal blood?
A
foetal haemoglobin has higher oxygen affinity than adult haemoglobin so it can take oxygen from maternal blood to the foetus
13
Q
factors which affect O2 affinity for haemoglobin:
A
- conc. hydrogen ions
- conc. carbon dioxide
- temperature
- carbon monoxide
- 2,3 diphosphoglycerate
- oxidation of iron in haemoglobin
14
Q
H+ conc. effect on O2 affinity for haemoglobin:
A
The Bohr effect: as [H+] increases, affinity for oxygen decreases which favours oxygen release in metabolising tissue
15
Q
CO2 conc. effect on O2 affinity for haemoglobin:
A
The Haldane effect- as [CO2] increases, the affinity for oxygen decreases as CO2 reacts with amino groups
16
Q
temperature effect on O2 affinity for haemoglobin:
A
as temperature increases, affinity for O2 decreases (eg. O2 is released when temperature rises ie. In muscle)
17
Q
2,3 diphosphoglycerate effect on O2 affinity for haemoglobin:
A
lowers O2 affinity
18
Q
carbon monoxide effect on O2 affinity for haemoglobin:
A
binds to Hb with an affinity 200 times greater than oxygen- also affects affinity of remaining sites as affinity for oxygen is increases so oxygen is released poorly in metabolising tissue
19
Q
Oxidation of iron in haemoglobin effect on O2 affinity for haemoglobin:
A
- Oxidation of iron in haemoglobin to Fe3+ converts it to methemoglobin which does not bind oxygen- methemoglobin reductase reduces this back to Fe2+
20
Q
carbon dioxide carriage in blood
A
Co2 is far more soluble than oxygen in blood but only a small proportion of CO2 is directly dissolved. Three mechanisms contribute to bulk of transport: bicarbonate- mediated transport, carbamino-mediated transport and dissolution.
21
Q
60% of carbon dioxide transport is mediated by:
A
HCO3 through an equilibrium between plasma Co2 and carbonic acid (H2CO3), which is important in pH regulation.
carbonic anhydrase within the red blood cells quickly converts the carbon dioxide and water into carbonic acid, which immediately dissociates into bicarb ions and H+ ions. this reaction allows for the continued uptake of carbon dioxide into the blood down its concentration gradient.
22
Q
30% of carbon dioxide transport is carried out by:
A
carbamino groups
The N-terminus of proteins contains a free NH2 group which can combine with CO+2 to produce a carbamino group. This reaction is readily reversible releasing CO2¬ if the pCO2 falls. Most carbamino groups are found on the peptide chains haemoglobin.
23
Q
does deoxyhaemoglobin or oxyhaemoglobin have higher capacity for forming carbamino groups?
A
Deoxygenated haemoglobin has a higher capacity for forming carbamino groups than oxygenated haemoglobin.
24
Q
10% of carbon dioxide transport
A
is transported dissolved in blood. The dissolved amount proportional as always to the partial pressure of the solution.
25
why is chorine important in bicarbonate mediated carbon dioxide transport?
Bicarbonate can diffuse out of cells but H+ cannot cross the erythrocyte membrane so Cl- transport into the cell is necessary to maintain charge neutrality across the membrane
In venous blood, more CO2 is present and therefore more intracellular Cl- is found.
26
elasticity of lungs and chest wall
- The lungs and chest wall are elastic: lungs tend to recoil inwards and the chest wall resists being distorted inwards from its natural resting shape resulting in an outward force
27
inspiration process
- Inspiratory muscles (diaphragm, external intercostals) contract and thoracic cage expands
- Pleural pressure becomes more negative relative to atmospheric: this negative pressure is transmitted to the alveoli
- Air flows into the lungs down the pressure gradient from mouth to alveoli and the lungs inflate
- The incoming air holds the small intrathoracic airways wide open
28
resting breathing expiration process
- Inspiratory muscle activity ceases and elastic recoil causes lungs to shrink- expiration is passive
- Elastic recoil produces positive pressure in the alveoli
- Air moves down pressure gradient from alveoli to mouth
- Small intrathoracic airways tend to be compressed and narrowed by surrounding alveoli during expiration
29
Vt:
tidal volume, volume of gas breathed in or out of the lungs with each normal breath (litres)- normal resting value 0.4-0.8 litres
30
fR:
respiratory frequency, number of breaths per minute- normal resting values 12-15 breathes/ min
31
Ve:
minute ventilation; the amount of gas breathed in or out of the lungs per minute (litres/min)- normal resting value 5-8 l/min
32
large/ forced expirations process
- Expiratory muscles (internal intercostals, abdominal muscles) contract depressing rubs, pushing diaphragm up, reducing thoracic volume and so increasing alveolar pressure and airflow
- Maximum airflow limited by compression of small intrapulmonary airways by surrounding alveoli
33
what does the CNS control in breathing?
the rhythmical contraction and relaxation of the respiratory muscles (diaphragm, intercostals)
34
basic breathing rhythm is generated in the
medulla
35
removal of the upper part of the pons in animals results in
slow, gasping breathing, suggesting neurones in this area help to control breathing
36
Main areas of respiratory neurones in the medulla and pons:
1. Ventral Respiratory Groups (VRG)
ventrolateral side of the medulla, contains inspiratory and expiratory neurones
2. Dorsal Respiratory Groups (DRG)
In the floor of the 4th ventricle- predominantly inspiratory neurones, pacemaker of controlled breathing
3. Pontine Respiratory Group (PRG)
Bilateral areas in the upper pons, contains neurones that are active in both inspiratory and expiratory phases
37
functional model of generation of breathing rhythm
* Discharge from the inspiratory neurones activates the respiratory muscles via spinal motor nerves, resulting in inspiration
* Expiratory neurones fire and inhibit the inspiratory neurones. Nerve impulses to the inspiratory muscles stop and passive expiration occurs.
* If forceful expiration is required, expiratory neurone activity also activates expiratory muscles to enhance expiration
38
reflux sensory information affecting breathing
* sensory information originates in lungs
* afferent fibres carried in vagus nerves (cranial X)
* activation initiates expiration
* sectioning the vagus nerves causes prolongation of inspiration (i.e. expiration is not commenced)
39
Rapidly Adapting (irritant) Receptors:
- sub epithelial mechanoreceptors in the trachea and bronchi, stimulated by inhaled irritants or mechanical factors, such as smoke, dust and chemicals such as histamine
- cause coughing, mucus production and bronchoconstriction
- their afferent fibres are myelinated
40
Slowly Adapting (stretch) Receptors:
- mechanoreceptors located close to airway smooth muscle, which are stimulated by stretching of airway walls during inspiration
- help prevent over-inflation by initiating expiratory rhythms.
- important role in the Hering-Bruer reflex (prolonged inspiration causes prolonged expiration). Afferent fibres are also myelinated
41
C fibres:
- unmyelinated nerve endings stimulated by oedema and various inflammatory mediators such as histamine and bradykinin
- cause rapid, shallow breathing and dyspnoea
42
Normoxia
- O2 in normal range
43
Hypoxia
- fall in O2 below normal (strictly speaking relates to O2 in a gas)
44
Hypoxaemia
- fall in O2 below normal in blood
45
Hyperoxia
- rise in O2 above normal
46
Normocapnia
- CO2 in normal range
47
Hypercapnia
- increase in CO2 above normal level
48
Hypocapnia
- fall in CO2 below normal
49
sites of peripheral and central chemoreceptors
Central chemoreceptors on ventrolateral surface of medulla
| Peripheral chemoreceptors in carotid bodies
50
peripheral chemoreceptors have a fast response to
arterial pO2, pCo2 and arterial [H+]
51
central chemoreceptors have a slow response to
respond indirectly and slowly to changes in arterial pCO2; CO2 crosses blood-brain barrier, produces [H+] ions which stimulate receptor cells
52
hypercapnia leads to
Linear increase in minute ventilation (Ve); this happens almost instantaneously when pCO2 rises above normal levels.
30% of the response caused by the peripheral chemoreceptors; fast response (2-4 sec)
70% caused by central chemoreceptors; slow response (4 min to reach maximum response)
53
minute ventilatory responses to hypercapnia
- Increased by hypoxia: decreased by hyperoxia
| - Interaction mediated at the peripheral chemoreceptors
54
hypocapnia leads to
little change in ventilation- dog leg of curve
55
hypoxia leads to
Curvilinear increase in ventilation.
There is little change in ventilation until pO2 has fallento about 8 kPa (60 mmHg), then a sharp increase. - mediated by peripheral chemoreceptors
56
hyperoxia leads to
small decrease in ventilation as tonic activity of chemoreceptors is switched off.
57
response to hypoxia
* increased by hypercapnia
| * interaction mediated at the peripheral chemoreceptors
58
Severe chronic airflow obstruction causing failure of normal chemoreceptor control of breathing
- Lungs unable to excrete metabolic CO2 load
- Chronic hypercapnia - desensitises central chemoreceptors
- Patient becomes dependent on hypoxic drive to breathe
- In this situation ONLY, giving high flow oxygen can dangerously suppress breathing- can lead to CO2 narcosis and death
- Avoid by using controlled low-flow oxygen therapy in emergency situations in these patients only
59
altered control of breathing during sleep
- Respiratory drive decreases (loss of wakefulness drive)
- Partly related to reduction in metabolic rate partly due to reduced input form higher centres such as pons and cortex
- Also- loss of tonic activity (state of continuous activity that exists in both the sympathetic and parasympathetic divisions) to upper airways
60
Consequence of loss of wakefulness drive:
patients with diminished capacity to ventilate (eg. muscle weakness, severe lung disease, neuropathy or spinal deformity) first develop respiratory failure (raised arterial CO2) during sleep
61
obstructive sleep apnea
* some patients have narrowed upper airway due to structural difference (shape of jaw) or excess fat around the neck
* during sleep, loss of upper airway tone allows upper airways to collapse
* can cause cessation of breathing in excess of 1 minute
* occurs in approx. 2% of population
62
drugs that depress breathing
almost all anaesthetics, opioids, benzodiazepines
63
drugs that stimulate breathing
doc-ram (now rarely used), beta 2 agonists
64
mechanical and immunological defences of the body
Mechanical: ciliated epithelium, mucus, cough
Immunological: IgA and antimicrobials in mucus, resident alveolar macrophages & dendritic cells, innate/ adaptive immune responses
65
parenchyma
the parts of the lungs involved in gas transfer including alveoli, interstitium, blood vessels, bronchi and bronchioles
66
microorganisms involved in community acquired pneumonia
* Streptococcal pneumoniae
* Haemophilus influenzae
* Moraxella catarrhalis
* Klebsiella pneumoniae/ Pseudomonas aeruginosa
* Mycoplasma pneumoniae
67
microorganisms involved in hospital acquired pneumonia
* Gram negative rods, Enterobacteriaceae, pseudomonas
| * MRSA
68
microorganisms involved in aspiration acquired (oral/gastric contents in bronchial tree) pneumonia
• Anaerobic oral flora mixed with aerobic bacteria
69
microorganisms involved in immunocompromised host pneumonia
* Cyclomegalovirus
* Pneumocystis jiveroci (PCP)
* Mycobacterium avium-intracellulare
* Invasive aspergillosis
* Invasive candidiasis
70
microorganisms involved in necrotising/ abscess formation pneumonia
• Anaerobes, S. aureus, Klebsiella, S. pyogenes
71
clinical presentation of pneumonia
- Cough
- Sputum
- Pyrexia
- Pleuritic chest pain
- Haemoptysis
- Dyspnoea
- Hypoxia
72
appearances of pneumonia
1. Bronchopneumonia
- Most common pattern
- Patchy consolidated areas of acute supprative (pus) inflammation
- Often elderly with risk factors- cancer, heart failure, renal failure, stroke, COPD
2. Lobar pneumonia
- Rust coloured sputum
- S.pneumoniae
- Consolidation of a large portion of a lobe or an entire lobe
73
local factors of pneumonia
Local Factors:
- Loss or suppression of the cough reflex- drugs
- Injury to the mucocilliary apparatus- viruses, gases
- Accumulation of secretions- CF, obstruction (tumour)
- Impaired alveolar macrophages function- alcohol, tobacco
- Pulmonary congestion and oedema
74
complications of pneumonia
Local: abscess formation, parapneumonic effusion, empyema
Systemic: sepsis, ARDS, multi-organ failure
If not resolving, could be cancer?
75
acute respiratory distress syndrome (ARDS): definition, clinical diagnosis, causes
- Respiratory failure characterised by rapid onset of widespread inflammation in the lungs
- Clinical Diagnosis: Hypoxia (PaO2/FiO2 ≤ 300mmHg), Non-cardiogenic pulmonary oedema
- Causes
Direct- pneumonia, aspiration, hyperoxia, ventilation
Indirect- sepsis, trauma, pancreatitis, acute hepatic failure
76
Bronchiectasis: definition and causes
- Permanent dilation of one or more large bronchi
- Typically affects the 2nd to 8th order of segmental bronchi- large central airways more robust
Causes:
- Infection: mycobacterial
- Hereditary: cystic fibrosis
- Immunodeficiency
- Chemical injury/aspiration
- Idiopathic
77
cystic fibrosis
- Autosomal recessive genetic disease
- CFTR encodes its protein, a chloride and bicarbonate ion channel present on cell membranes
- Difficult for patients to clear mucus
- Multi-system disease affecting the GI tract, liver, reproductive system
- death is principally related to airways inflammation and infection leading to respiratory failure, which occurs from childhood
78
tuberculosis risk factors
- TB contact
- Very young/elderly
- Immunosuppression
- Malnutrition/ alcoholism
- Live or visit TB endemic countries
- Health care worker
79
Primary TB: 3-4 weeks
- Mycobacterium tuberculosis multiplies within alveolar macrophages (naïve, unable to kill)
- Bacterium resides in phagosomes carried to regional lymph nodes from there to circulation
80
Primary TB: 3-8 weeks
3-8 weeks
- Onset of cellular immunity & delayed hypersensitivity
- Activated lymphocytes further activate macrophages to kill
- Primary infection arrested in most immunocompetent people
- Few bacilli may survive dormant
81
progressive primary TB
- Infection may not be arrested in minority- infants, children, immunocompromised
82
tuberculous bronchopneumonia
- Infection spreads via bronchi
- Results in diffuse bronchopneumonia
- Well-developed granulomas do not form
83
military TB
- Infection spreads via bloodstream
- Organisms scanty (small or insufficient in quantity)
- Multiple organs- lungs, liver, spleen, kidneys, meninges, brain
84
Secondary TB (also called ‘post primary’ TB)
- Reactivation of old, often subclinical infection
- More damage due to hypersensitivity
• Apical region of lung
• Tubercles develop locally, enlarge and merge
• Erode into bronchus and cavities develop
• May progress into tuberculous bronchopneumonia
85
asbestos fibrosing lung disease
occupational lung disease, exposure in shipyards, building trade. Pleural plaques can lead to mesothelioma and adenocarcinoma.
86
- Hypersensitivity pneumonitis (fibrosing lung disease)
Type 3 hypersensitivity reaction eg. pigeon fancier’s lung, mushroom lung, hot tub lung- normally resolve when agent is resolved but can be chronic
87
Usual interstitial pneumonitis-
fibrotic foci, mixed inflammatory infiltrate, excess alveolar macrophages
progressive scarring of both lungs
88
symptoms fo restrictive chronic lung disease
dyspnoea, tachypnoea, late stage cyanosis and inspiratory crepitation
89
causes of lung cancer
- Smoking (>95%)
- Occupational hazards- uranium mining, asbestos exposure
- Environmental exposure- radon gas
- Genetic- Li- Fraumeni Syndrome (mutated p53 gene)
- ? viral infection- retroviral infection in sheep leads to lung adenocarcinomas
90
types of lung cancer
- Squamous carcinoma
- Adenocarcinoma
- Small cell carcinoma
- Other- carcinoid tumours
91
mechanisms of carcinogenesis
* Oncogenes are mutated genes encoding growth- promoting proteins – these are overexpressed in neoplasia eg k-Ras, cylinD1
* Oncosuppressor genes are mutated genes encoding growth-inhibitory proteins – decreased expression can result in neoplasia eg retinoblastoma gene (Rb)
* Genes regulating apoptosis may also be mutated eg p53
* Genes regulating DNA repair may be mutated
92
Classification & Clinical Significance of Carcinoid/ Neuroendocrine Tumours in the Lung
```
- Typical (classical) carcinoid
• <2 mitoses per 2mm2
• No necrosis
• 10-15% have hilar nodal involvement
• Feq eventually develop in distant sites
```
- Atypical carcinoid
• >2 but <10 per 2mm2
• Focal necrosis (may be focal commedo like)
• >10 mitoses per 2mm2 with usually extensive necrosis then classified with LCNEC
• 40-50% have nodal metastases
93
Squamous metaplasia
- Common finding in smokers
- Airways become lined with squamous epithelium rather than normal respiratory epithelium
- Reversible
94
Adenocarcinoma: arises, commonly invades & metastasises
| associated with and diagnosis
- Arise peripherally from mucous glands and the cells retain some of differentiation and mucus production
- Commonly invade pleura and mediastinal lymph nodes
- Commonly metastasise to brain and bones
Associated with: smoking, asbestos exposure, arises around scar tissue
- Distinguished using CT scans and other investigations to check for the primary as they are similar to secondary tumours
95
symptoms and signs of adenocarcinoma
Symptoms of Lung Cancer
- Cough
- Dyspnoea
- Haemoptysis
- Chest/shouder pain
- Hoarseness
- Fatigue
Signs of Lung Cancer
- Slow to clear pneumonia
- Finger clubbing
- Cervical lymphadenopathy
- Liver, bone, brain metastases
- Pleural effusion
96
diagnosis of lung cancer
```
Biopsies
- Bronchial biopsies
- CT guided lung biopsies
- Biopsies of distant metastases eg. pleura, liver, lymph node
Cytology
- Bronchial brushings and washings
- Sputum
- Pleural fluid aspiration
- Fine needle aspirates of metastases
```
97
behaviour of lung cancer
Intrapulmonary growth
- Obstructive pneumonia
- Lymphangitis carcinomatosis
Invasion of adjacent structures: pleura, chest wall, mediastinum, diaphragm
Distant metastases via lymphatics and blood: hilar and mediastinal nodes, liver, bones, brain
98
lymphoid infiltration in lung carcinomas may be associated with
better outcomes
99
screening for lung cancer
* Screening with LDCT (low dose CT) can detect early stage lung cancer
* CXR/sputum cytology as screening has no effect on mortality
100
Process by which squamous cell carcinomas develop into necrotic masses
- Secretes tumour angiogenesis factors which causes blood vessels to grow into the mass of tumour cells- allows rapid growth and size increase
- If the tumour grows too large for its blood supply then the central area can become deprived of oxygen and nutrient leading to necrotic areas
101
options for lung cancer treatment
* Resection- only 7-10% suitable, 5 year survival, 70%
* Concurrent chemo-radiotherapy- 5 year survival, 30%
* Palliative chemotherapy- overall survival benefit, few months
* Palliative radiotherapy- symptom control
* Best supporting care- symptom control
102
lung function after operations in lung cancer
- Lobectomy- early deficit with later recovery, no decrease in exercise capacity & little permanent loss in PFT
- Pneumonectomy- early permanent deficit, decrease in exercise capacity & PFT
103
groups of patients respond well to EGFR blocking therapy-
East Asian, adenocarcinoma, females, non-smokers
104
small cell lung cancer: characteristics, staging, prognosis
- Very aggressive tumour
- Early dissemination
- Virtually all patients have metastatic spread at presentation
Staging
Limited Disease: restricted to one hemithorax ± ipsilateral nodes
Extensive disease: spread beyond one hemithorax
Prognosis
- Sensitive to chemotherapy and radiotherapy
- Long term survivors <5% of patients
105
Bacteriostatic-
stops bacteria from reproducing, while not necessarily killing them otherwise
106
Bactericidal-
kills bacteria, particularly preferred in serious infection
107
cell wall inhibitors function
- Selectively toxic to bacteria because there is no cell wall in mammalian cells
- Removal of cell wall destroys bacterial maintenance of osmotic pressure
- Usually bactericidal in action
- Bacitracin acts at Gram positive cell membrane
108
cell wall synthesis inhibitors examples
- Beta- lactams
- Glycopeptides eg. vancomycin
- Fosfomycin
- Bacitracin
109
beta lactase- structure and mechanism
examples: penicillins, cefalosporins, carbapenems, monobactams
- All possess a beta lactam ring
- Differ in side chains attached to this nucleus
- Target site is peptidoglycan which is present in only bacteria
Mechanism: act in the final step of cell wall synthesis by binding to enzymes responsible for cross linking of polysaccharide chains in the cell wall peptidoglycan (also known as transpeptidases or ‘penicillin binding proteins’)
110
Cmax:
the maximum serum concentration that a drug achieves in a specified compartment or test area of the body after the drug has been administrated
111
Tmax:
the term used to describe the time at which the Cmax is observed
112
oral drugs characteristics
must be able to survive acidic conditions of the stomach
- may do this either by resistance to acid destruction, or they may have functional groups added to form esters, which are then cleaved by acids to form functional antibiotics.
- typically indirect; have to go around the body in the circulation to reach the site of infection.
- easier and cheaper to administer
113
what are different types of beta lactams used for?
penicillin: Group A step, meningococci
cefalosporin: broader spectrum, not enterococci (gram positive)
carbapenem= broad spectrum
114
side effects of beta lactase
- Hypersensitivity rash, allergy
- Avoid amoxicillin in patients with mono- EBV
- Rare: anaphylaxis but can be fatal
- Excreted by kidneys: must reduce dose in renal failure
- Diarrhoea- not uncommon
115
beta lactamase stability
cefalexin< cefotaxime < ceftazidime
116
glycopeptides- cell wall synthesis inhibitor
- Eg. vancomycin
- Inhibit cell wall synthesis by binding to terminal D-ala-D-ala of the peptide chain and prevents incorporation of new subunits to the growing cell wall
- For gram positives not gram negatives- important in MRSA infection
- nephron and toxicity- check levels
117
protein synthesis inhibitors
- Aminoglycosides eg. gentamicin
- Tetracyclines
- Macrolides (erythromycin, clarithromycin)
- Chloramphenicol (rarely used in UK)
- Lincosamides
- Oxazolidones
- Fusidic acid
118
aminoglycoside- protein synthesis action, used for, side effects
eg. gentamicin
- Inhibit binding of 30S subunit to mRNA =protein synthesis inhibited
- Very good vs gram negatives eg. E.coli, Pseudomonas aeruginosa, Mycobacteria ect.
- Anti-staphylococcal activity
- broad spectrum
- Ototoxic and nephrotoxic
- Monitor serum levels during therapy
119
tetracycline- protein synthesis inhibtion action, used for, side effects
action: Inhibit binding of tRNA= protein synthesis inhibited
- Bacteriostatic, Broad spectrum
- Intracellular bacteria eg. chlamydia
- May cause diarrhoea, nausea
- Teeth discolouration, avoid in children, pregnant & lactating women
120
macrolides- protein synthesis action, used for, side effects
- Erythromycin, clarithromycin
action: Prevent peptidyl transferase from adding the growing peptide attached to tRNA to the next amino acid = protein synthesis inhibited
Narrow spectrum: Gram positive- S.aureus, Group A streptococci, legionella, chlamydia, pneumonia (atypical, in COPD exacerbations)
[newer have broader spectrum eg. clarithromycin]
SE: GI upset common
- Thrombophlebitis when given intravenously
121
Lincosamides- protein synthesis inhibitors
eg. clindamycin
Bacteriostatic against gram positives(especially Group A streptococci) and anaerobes
action: bind to 50S subunit = protein synthesis inhibited
side effects: diarrhoea/ colitis
122
THFA inhibitors nucleic acid action and examples
THFA inhibitor act on nucleic acid synthesis
Sulphonamides–structural analogues of PABA (para‐aminobenzoic acid)
Trimethoprim–‘folate' antagonist, binds dihydrofolate reductase.
Individually these drugs are bacteriostatic, together they are bactericidal
123
when should trimethoprim not be given?
in pregnancy
124
cotrimoxazole
combined trimethoprim and sulphonamides
- There is in vivo energy between the drugs- combined effect if greater than expected sum of activities- used in pneumocystis pneumonia
- in UK trimethoprim is used for UTI but cotrimoxazole use increasing
125
RNA synthesis inhibitors action:
- Binds to DNA dependant RNA polymerase
- Forms stable complex with beta subunit (encoded by rpoB gene mutates readily)
- Inhibits intiation- not elongation
- Usually bactericidal
126
RNA synthesis inhibitors examples, use, SE
rifampcin
used for TB (in combination)
side effects: drug interactions: inactivates oral contraceptive, hepatitis, nausea, body fluids go orange
127
DNA Synthesis Inhibitors- Quinolones action
- Act by inhibiting DNA gyrase (gram negatives) and topoisomerase IV (gram positives) so DNA coiling inhibited
- Bactericidal
128
fluoroquinolone example, uses, side effects
Ciprofloxacin
- Broad spectrum
previously used for anthrax, now meningococcal contact prophylaxis, UTI, typhoid
side effects:
- Neurotoxicity, confusion, fits
- Cartilage defects, not used in pregnant women and children
- Photosensitivity
- Association with C.difficile
129
broad spectrum antibiotics associated with C.diff (4Cs)
Co-amoxiclav
Clindamycin
Ciprofloxacin and other quinolones
Cephalosporins
130
benefits of combination therapy
Delay emergence of resistance
Allow smaller doses of each agent (synergy)
Useful if awaiting laboratory results while patient is in severe sepsis
For example: trimethoprim and sulfonamide for pneumocystis pneumoniae
131
cons for combination therapy
Worse side effects
Disturb normal gut flora, cause diarrhoea, thrush
Superinfection by resistant bacteria
Additive toxicity –for example, the use of vancomycin & gentamicin or quinolones & macrolides can cause QT prolongation and arrhythmias
132
factors that promote antibiotic resistance
1. Antibiotic Usage- too much or too little
2. Effective Genetic Mobility- plasmid carriage, transposons, integrons
3. Efficient Resistance Mechanism- bacterial factors
133
action of resistance genes
chromosome, plasmid, transposon, integron
134
mechanism of resistance- target site alteration
Target site alteration, e.g. bacterium modifies target site so affinity of drug for site is reduced, antibiotic cannot bind
135
mechanism of resistance- reduced access
Reduced access e.g. antibiotic removed from bacterial cell, or bacteria no longer permeable to drug
136
mechanism of resistance- drug inactivation
Inactivation of drug e.g. beta lactamases are enzymes produced by bacteria which deactivate the beta lactam ring in certain beta lactam antibiotics, such as penicillin. Clavulanic acid can be given with these antibiotics –it binds to beta lactamases and inactivates them, allowing the antibiotics to work
137
mechanism of resistance- metabolic bypass and hyper production
Metabolic bypass through production of additional target so new drug‐resistant metabolic enzyme produced to bypass the inhibited metabolic stage
Hyper-production - overproduction of antibiotic target (titration) for secondary ‘additional’ targets
138
intergrons
- Gene capture and expression systems
- Usually resides on transposon
- Able to poach resistant genes ie. extract DNA segments and inserts into other DNA segments
139
Resistance Control Strategies
1. Conservation
- Remove devices eg. urinary and central catheters
2. Prudent use- discourage topical, date for stopping
3. Surveillance
4. Infection control eg. hand disinfectant
140
oxygen requirement and carbon dioxide production at rest
Oxygen requirement at rest= 250ml/min
| Carbon dioxide production at rest= 200ml/min
141
gas transfer requirement of surface area between air (alveoli) and blood (capillaries)
there is extensive branching in both bronchial and arterial anatomy. Blood vessels branch more than bronchi so have bigger airspaces with smaller vessels.
Airways and vessels have thin walls. Large surface area of air in contact with blood.
142
Equilibrium of Partial Pressure-
diffusion of oxygen down a partial pressure gradient
| At equilibrium, partial pressure of gas in solution= partial pressure of gas above liquid
143
oxygen and Hb dissociation
* The affinity of binding O2 increases with each successively bound O2 molecule- allosteric effect
* Once bound, a number of factors can alter ability of Hb to take up and liberate oxygens
* Ultimately want Hb to take up O2 in the lung and liberate O2 at the tissues (muscles)
144
oxygen content and partial pressure in capillary blood
Pulmonary arteries are pumping in deoxygenated blood into small vessels . Oxygen moves from the alveolus into the capillary blood until the partial pressure of the oxygen equilibrates.
145
why is partial pressure of oxygen in mixed alveolar gas higher than that of arterial blood?
due to shunting- leads to PO2 being lower than expected
146
anatomical shunts
* Small amount of arterial blood doesn’t come from lung (Thebesian veins- drain heart muscle back into heart)
* Small amount of blood goes through without seeing gas (bronchial circulation- arteries that oxygenate lung tissue)
147
physiological shunts and alveolar dead space
Physiological shunts (lower V) and alveolar dead space (lower Q)
• Not all lung units have same ratio of ventilation to blood flow
• V/Q mismatch
148
Factors that can decrease the partial pressure of oxygen in the blood:
* Hypoventilation- less oxygen to enter the blood, less air enters and leaves the alveoli, decreased alveolar oxygen
* Decreased environmental oxygen eg. altitude
149
Factors that can increase the partial pressure of oxygen:
* Hyperventilation- PO2 is higher but oxygen content isn’t that much higher
* Administration of oxygen
150
increase in available pO2 in healthy state leads to
* Slight increase in Hb saturation
* Little change in oxygen content
* At a normal PO2, blood carried nearly as much oxygen as it possibly can so increasing PO2 has very little effect on oxygen content
151
Ventilation to Perfusion Ratio (V/Q)
* If ventilation= perfusion then perfect gas exchange
| * In the lung, you naturally have V/Q mismatch with less blood and air going to the top of the lung
152
normal V/Q mismatch in different parts of the lung
Top of Lung: less airflow and blood flow but V>Q= higher V/Q
Middle of lung: normal
Bottom of lung: more ventilation and more blood flow but V
153
increased V/Q Ratio means that
* Lots of ventilation to alveoli, not much blood
* Alveoli and blood reach an equilibrium which is closer to air
* The region of the lung with the high V/Q ratio has a higher PO2 (and a lower PCO2) than other regions
154
decreased V/Q Ratio means that
* Less ventilation to alveoli, lots of blood
* Alveoli and blood reach an equilibrium which is closer to venous blood
* PO2 is therefore lower (and PCO2 is higher)
155
Alveolar dead space=
areas of insufficient blood supply for gas exchange and appears with age and disease
156
Anatomical dead space=
conducting airways where no gas exchange takes place
157
Physiological dead space=
There are some areas of high and low V/Q ratios
| PDS= anatomical dead space + alveolar dead space
158
quantifying V/Q mismatch
* Calculate expected alveolar PO2 (PAO2) using the alveolar gas equation
* Compared with the measured arterial PO2 (PaO2)
* If PAO2= PaO2 then no mismatch
159
A-a gradient and reasons for a high A-a gradient
• Shows difference between alveolar and arterial oxygen level
• Can help to diagnose the cause of hypoxaemia
• High A-a gradient could be due to:
- Problem with gas diffusion
- V/Q mismatch
- Right to left shunt
160
Arterial blood gases (ABG) are used to assess
hypoxaemia
161
respiratory vs ventilatory failure
Respiratory failure- failure to oxygenate properly leading to hypoxaemia
Ventilatory failure- failure of the ventilatory pump mechanism leading to hypoxaemia
162
Why do patients become hypoxic?
- Hypoventilation
- Ventilation perfusion (V/Q) mismatch (pathological vs. physiological)
- Both
163
hypoventilation leads to
- Oxygen levels of down in hypoventilation
- During normal ventilation CO2 diffused out of blood into alveolus following a partial pressure gradient
- If there is lower ventilation, then CO2 accumulates in the alveolar space meaning less can be removed by blood
- O2 decreases while CO2 increases
164
if PaO2 lower than expected =
respiratory failure (PaO2< 8 kPa)
165
causes of failure of the ventilatory pump
Won’t breathe: control failure
- Brain failure to command eg. drug overdose
- Sometimes in COPD
Can’t breathe: broken peripheral mechanism
- Nerves not working e.g phrenic nerve cut
- Muscles not working eg. muscular dystrophy
- Chest can’t move eg. severe scoliosis
- Gas can’t get in and out eg. asthma/COPD
166
type 2 respiratory failure: definition, causes
- Decrease in PO2
- Increase in PCO2
Common causes in hospital:
Severe COPD (can be acute or chronic)
Acute Severe Asthma
Pulmonary Oedema in acute Left Ventricular failure
- Due to hypoventilation as main feature
167
treatment of type 2 respiratory failure
- Oxygen- controlled in COPD patients with chronic respiratory failure
- Treat underlying cause to reverse hypoventilation eg. bronchodilators for acute asthma or opiate antagonists for overdoses
- Support ventilation- invasive or non-invasive
168
non invasive ventilation
- Common treatment for COPD exacerbations with type 2 respiratory failure
- Tight fitting mask, no need for sedation and incubation
- Increased ventilation efficiency
- Also useful in neuromuscular disease and thoracic wall disease
169
causes of V/Q mismatch
- Most lung disease effecting the airways and parenchyma
- Lung infection such as pneumonia
- Bronchial narrowing such as asthma and COPD (can also progress to Type 2 resp failure)
- Interstitial lung disease
- Acute lung injury
170
creation of shunt due to pneumonia
Pneumonia causes inflammation and damage in the small airways and alveoli. This creates a shunt leading to low PO2 because blood does not come into contact with adequate O2.
171
V/Q mismatch due to perfusion problems
Pulmonary embolism
- Can range from small PTE (pulmonary thromboembolism) causing no problem with gas exchange to massive PE with hypoxia
- Emboli effectively causes areas of dead space where there is ventilation but no perfusion causing hypoxia
172
asthma and respiratory failure
- Hypoxaemia suggests significant asthma attack
- Bronchospasm and mucous plugging causes ventilation defects and V/Q mismatch
- Type 2 resp failure develops when severe bronchospasm causes hypoventilation fo alveoli or exhaustion
- Patient needs oxygen to survive, invasive ventilation may be required
173
COPD and respiratory failure
- COPD is a mixture of chronic airways inflammation and narrowing and emphysema
- Problems with V/Q mismatch and hypoventilation
- May present acutely with both types of resp failure
- May have chronic type 2 resp failure in advanced disease
- Treat resp failure with oxygen but with caution in chronic type 2 resp failure
174
oxygen therapy masks
- Variable performance- cheap, exact inspired O2 concentration not known
- Fixed function- constant, known inspired concentration
- Reservoir mask- high inspired concentration of O2
Venturi Mask- pre mixed gases, accelerate gas through nozzle, controlled oxygen therapy, aim to supply oxygen at flow rate faster than the patient can breath
175
how do we quantify oxygen carriage?
1. Haemoglobin saturation
- If Hb is normal, accurate reflection of oxygen content
Oxygenated haemoglobin is RED
Deoxygenated haemoglobin in BLUE
- Using absorption spectroscopy, it is possible to estimate the degree of saturation of haemoglobin
- SpO2, pulse oximetry
2. Arterial blood gases
- PaO2 reflects haemoglobin saturation but is a measure of the partial pressure of O2 in the blood
176
How to measure ABG?
- Single arterial puncture technique- radial/ femoral/ branchial artery
- Measurement from in-dwelling arterial catheter of A-line (only an option in HDU/ITU)
177
difference between PA and Pa
```
PA= partial pressure in alveolus
Pa= partial pressure in arterial circulation
```
178
Carbon Monoxide Poisoning
- CO is produced form incomplete combustion of hydrocarbons
- CO binds to haemoglobin (high affinity) in the place of oxygen to form carboxyhaemoglobin
- Also interferes with mitochondrial respiration
- Death by asphyxia
- Treatment is high conc. Oxygen (to displace CO from haemoglobin)
179
effects of ventilation on pCo2 and CO2 content
- More ventilation= low pCO2 and content
- Less ventilation= high pCO2 and content
- Hypoventilation causes build-up of alveolar CO2 and therefore less is removed form blood
- Increase in blood CO2 leads to acidosis
180
blood gases in type 1 respiratory failure
- low PaO2- blood not being oxygenated on passage through pneumonic lung
- normal (or low) CO2
caused by V/Q mismatch decreasing adequate gas exchange eg. pneumonia
- Patient breathes faster so can get rid of excess CO2 but can’t increase O2
181
blood gases in type 2 respiratory failure
- low PaO2
- high PaCO2- due to increased levels in alveolar space and less removed from blood
- caused by hypoventilation
- may be acute or chroncic
- if acute, will have respiratory acidosis (high H+)
182
H+ is increased by:
An increase in pCO2 (respiratory acidosis)
| An increase in acid production or decrease in excretion (metabolic acidosis)
183
Acute vs Chronic Type 2 Respiratory Failure- hypoventilation
- Acute hypoventilation eg. due to opiate toxicity leads to hypoxia, hypercapnia and acidosis
- Chronic hypoventilation eg. neuromuscular disease of severe COPD leads to hypoxia and hypercapnia but may not have acidosis due to compensation
184
Compensation=
increased bicarbonate retention by the kidney compensates for acidosis
185
Respiratory Alkalosis
- Not usually associated with respiratory failure
- Caused by hyperventilation
- Have low PCO2 and low H+
186
metabolic acidosis
- Excess acid production by the body eg. lactic acidosis or diabetic ketoacidosis
- Sign= kussmal breading as a compensatory mechanism to increase CO2 removal from blood
- Full compensation is difficult: need ot treat the underlying cause of increased acid load eg. treat DKA
187
causes of respiratory and metabolic acidosis
```
Respiratory= if the pCO2 is high
Metabolic= if the standard bicarbonate is low, or the base excess has a more negative value than -2mmol/l, e.g -3mmol/l
```
188
Bicarbonate interpretation- increase and decrease
- HCO3- is increased by an increase in pCO2
| - decreased by an increase in acid production or decrease in excretion
189
actual and standard bicarbonate
Actual Bicarbonate= calculated with actual H+ and pCO2 values
Standard bicarbonate= calculated with actual H+ and a pCO2 of 5.3kPa (normal pCO2)
Standard bicarbonate is therefore only influenced by metabolic effects
190
base excess
BE= the amount of base needed to be removed from a litre of blood at a normal pCO2 in order to bring the H+ back to normal
- Calculated with normal CO2 so it only looks at the metabolic component
- Normal value: 0 (-2 to 2 mmol/l)
- A big negative value indicates a metabolic acidosis
- A big positive value is seen in compensated respiratory acidosis
191
acute bronchitis
- Inflammation of bronchi
- Often viral, may be bacterial eg. H.influenzae
- May also involve larynx and trachea- laryngeotracheobronchitis
- Acute exacerbations of chronic bronchitis are common
192
Bronchiolitis: definiton, types
- Inflammation of bronchioles
- A feature of chronic bronchitis
Primary bronchiolitis:
• Usually in children
• Respiratory syncytial virus (RSV)
• Tachypnoea and dysnpoea
- Rare types: follicular bronchiolitis, Bronchiolitis obliterans
193
Localised Airway Obstruction: causes, leads to
- Airway obstruction can be due to:
• Lesion outside the wall eg. large lymph node
• Lesion in the wall eg. tumour
• Lesion in the lumen eg. foreign body
- Causes distal collapse or over inflation
- May be distal, lipid or infective pneumonia
194
Diffuse Obstructive Airways Disease
- Reversible and intermittent or irreversible and persistent
- Centred on bronchi and bronchioles
- Diffuse disease as many airways involved
195
Pulmonary function tests ‘obstructive’:
Reduced vital capacity (VC)
• Reduced FEV1/ FVC ratio
• Reducing peak expiratory flow rate
196
COPD-
spectrum of co-existence of chronic bronchitis and emphysema
- Increased mucous production
- Destruction of alveoli and connective tissue leading to collapse of conducting airways
- Smoking= main cause
- Smokers have elastin degradation in the body also leading to small airway collapse
197
chronic bronchitis: definition, aetiology, clinical presentation
Clinical definition- cough and sputum for 3 months in 2 consecutive years
Aetiology- pollution, smoking
Clinical:
• Middle aged heavy smokers
• Recurrent low grade bronchial infections (exacerbations)
• H.influenzae, S.pneumoniae, viruses
• Airway obstruction may be partially reversible
198
chronic bronchitis: pathology
Pathology
- Respiratory bronchiolitis (<2mm diameter)
- Can lead to centrilobular emphysema
- Mucus hypersecretion- mucous gland hypertrophy
- Chronic bronchial inflammation- squamous metaplasia, increased risk of malignancy
199
progression of chronic bronchitis
- Hypercapnia
- Hypoxia
- Pulmonary hypertension
- Cor pulmonale- right ventricular failure
- Blue bloater- overweight and cyanotic
200
emphysema: definiton and clinical features
Anatomical Definition- irreversible dilatation of alveolar spaces with destruction of walls, associated with loss of surface area for gas exchange
Clinical Features
- Hyperventilation
- Normal pO2¬, pCO2
- Pink puffer
- Weight loss
- Right ventricular failure
- Often co-existing chronic bronchitis
201
classifications of emphysema
1. Centrilobular Emphysema
- Associated with smoking, seen in some pneumoconiosis- particularly coal workers
- Most commonly in upper lobes
- Respiratory bronchiolitis often present
2. Panlobular Emphysema
- Associated with alpha-1- antitrypsin deficiency
- Usually lower lobes
- Lungs overdistended
- Markedly accelerated in smokers with this disorder
3. Paraseptal Emphysema
- Distension adjacent to pleural surfaces
- May be associated with scarring
4. Irregular Emphysema
- Overlap with paraseptal emphysema
- Associated with scarring
5. Others
- Bullous: distended areas >10mm
- Interstitial
202
asthma definiton
- Reversible wheezy dyspnoea
| - Increased irritability of the bronchial tree with paroxysmal airway narrowing
203
atopic asthma
- Associated with allergy
- Can be triggered by: dust, pollen, house dust mite ect.
- Often includes eczema and hay fever
- Bronchoconstriction mediated by a type I hypersensitivity reaction
The hypersensitivity reaction often leads to:
- Bronchial obstruction with distal overinflation or collapse
- Mucus plugging of bronchi
- Bronchial inflammation
- Mucous gland hypertrophy
- Bronchial wall smooth muscle hypertrophy
- Thickening of bronchial basement membranes
204
Asthma can lead to sudden death due to
mucus plugging
205
types of asthma
1. Atopic Asthma
2. Non-Atopic Asthma
- Associated with recurrent infections
- Not immunologically medicated
- Skin testing negative
3. Aspirin- induced Asthma
- Associated with recurrent rhinitis, nasal polyps and urticaria
- Mechanism of asthma unclear
4. Occupational Asthma
- Hypersensitivity to an inhaled allergen
- May be non-specific in those with hyper-reactive airways
- May be a specific allergic response
5. Allergic bronchopulmonary aspergillosis (ABPA)
206
Allergic bronchopulmonary aspergillosis (ABPA)
- Specific allergic response to the spores of Aspergillus fumigatus
- Mixed type I and III hypersensitivity reaction
- Mucus plugs common
- Associated with bronchiectasis
- Not to be confused with an aspergilloma: fungal ball, usually colonising a pre-existing cavity in the lung (often tuberculosis)
207
bronchietstasis: definiton, clinical feature and complications
- Bronchial dilatation
- Acute & chronic inflammation, fibrosis
Clinical Features
- Chronic cough productive of copious sputum
- Finger clubbing
Complications
- Spread of infection- pneumonia, empyema (collection of pus in pleural cavity), septicaemia, menigitis, metastatic abscesses eg. brain
- Amyloidosis
- Respiratory failure
208
similarities between asthma and COPD
- Asthma usually due to atopic and allergen exposure whereas COPD is mainly due to smoking/ hydrocarbon exposure
- Asthma is characterised by reversible airways obstruction and an early and late phase response to stimuli
209
main effector cells of asthma and COPD
- Asthma- eosinophil main effector cell
| - COPD- neutrophil main effector cell, causes lung destruction
210
obstructive lung diseases
- asthma
- COPD
- Causing obstructive picture: bronchiectasis, cystic fibrosis- chronic destructive disorders that are associated with decreased lung function
211
Factors affecting Airway Internal Diameter:
- Increased mucus production- mucus normally sweeps along the airway, gel-like mucus sits above cilia with liquid between them
- Anatomical features
- Autonomic and non- adrenergic/ non cholinergic (NANC) systems
- Inflammation causing obstruction- COPD, asthma, cystic fibrosis
212
Autonomic and NANC Nervous Systems
- The lung contains muscarinic receptors and stimulation of these causes bronchoconstriction- COPD drugs act at these receptors
- The lung also contains beta-adrenergic receptors and stimulation of these causes bronchodilatation- salbutamol acts at this receptor
- receptors often found on smooth muscle cells
213
small decrease in airway radius=
big increase in resistance, decrease in airflow
214
Peak Flow
- Peak Expiratory Flow Rate (PEFR)
- Measures maximum speed of expiration
- Crude measurement of conducting air flow
- Can aid in asthma diagnosis/management
- Excellent bedside/patient based tool
- (cheap + easy to use)
215
Ratio of FEV1¬ to FVC
* Useful to differentiate between obstruction and restriction
* If ratio <0.7- then suggests obstructive airways pathology
* In mild obstruction, biggest impact on FEV1
* In severe obstruction, FVC can also be impacted
216
effect of mild/moderate obstruction on lung volumes
RV increased due to gas trapping and FVC slightly reduced but TLC normal as don’t have bad emphysema.
217
effect of severeobstruction on lung volumes
TLC increased as lung tissue destroyed and have emphysema. But due to loss of elastic recoil the effective FVC is decreased and the RV is massively increased
218
Reversibility of Spirometry
- Used as a diagnostic test in asthma eg. following bronchodilator
- Give salbutamol and wait 15 minutes
- Asthma reversible vs. COPD fixed airways obstruction
- Can also use bronchial challenge agents (histamine) to induce bronchospasm and obstructive spirometry
219
Restrictive Disorder-
a disorder which prevents normal expansion of the lungs
220
Lung restriction can occur due to:
- Extra-pulmonary disease i.e. Visceral pleura, pleural space, chest wall including parietal pleura, bones, muscles, nerves
- Intra-pulmonary disease i.e. Alveolar spaces
221
Types of Extra-pulmonary Restriction
1. Integrity of nerves to respiratory muscles eg. high cervical dislocation
2. Impaired neuromuscular junctions eg. myasthenia gravis
3. Impaired muscles eg. muscular dystrophy
4. Pleural thickening eg. asbestos exposure
5. Skeletal abnormalities eg. scoliosis
222
Types of Intrapulmonary Restriction: diseases causing increased fibrous tissue in the lungs
- Silicosis in a stonemason
- Asbestosis
- Drug induced lung fibrosis
- Coal workers pneumoconiosis
- Rheumatoid lung
- Bird fanciers lung
- Idiopathic pulmonary fibrosis
223
Inflation Pressure-
pressure delivered to alveoli, pressure that can be generated by intercostal muscles and the diaphragm into the alveolar space
224
Pulmonary Compliance-
the ability of the lungs to starch during a change in volume relative to an applied change in pressure (stretchability), fibrotic diseases can decrease pulmonary compliance
225
3. Elastic Recoil=
alveolar pressure – pleural pressure
226
effect of decreased compliance (rigidity/scarring) on inflation
- Less lung volume achieved for a certain pressure- high pressure required to inflate
- increased elastic recoil (deflates easily)
227
effect of increased compliance- more floppy (obstructive defect eg. emphysema)
- Increased lung volume achieved for a certain pressure
| - decreased elastic recoil (difficult to deflate)
228
large radius=
less effect of surface tension.
229
pressure inside alveoli according to Laplace’s Law for a sphere
Well inflated alveolus → large radius → relatively low alveolar pressure
Underinflated alveolus → small radius → relatively high alveolar pressure
230
Alveoli are connected so:
- Air moves from high pressure area to low pressure area
- Smaller alveolus empties into larger alveolus
- There is instability of adjacent alveoli- leads to respiratory failure
231
surfactant function
(surface active agent) in the alveolar lining fluid prevents collapse and keeps alveoli stable. It equals out the surface tensions of alveoli of different sizes eliminating different alveolar pressures- equal pressures can be achieved and surface tension is reduced
232
structure of surfactant
- Made of alveolar Type II cells
| - Composed of lipids (mostly phospholipids) and proteins
233
surfactant molecule interactions
- They can only exert their influence if they are close together and can interact
- Water molecules between surfactant molecules prevent them from interacting
234
surfactant mechanism of action on well expanded alveoli eg. inspiration
- Surfactant spread evenly over alveolar surface but molecules spread out and separated by water molecules
- Surfactant has little effect on surface tensions (sT)
235
surfactant mechanism of action on deflated alveoli eg. expiration
- Tightly packed surfactant molecules
- Some surfactant molecules extruded from the surface
- Surfactant significantly reduces sT with accompanying lower pressure
236
cause of respiratory distress syndrome of the new-born
lack of surfactant.
| Signs: low compliances, high inflation pressures, rapid shallow breathing → fatigue, hypoxaemia
237
Primary surfactant deficiency
very rare in adult disease but it can contribute to the pathogenesis of: ARDS, pneumonia, idiopathic pulmonary fibrosis, lung transplant
238
gas transfer measurement
Gas transfer is a measure of the diffusing capacity of the lung. It requires measurement of gas exchange and alveolar volume. Carbon monoxide (rapidly taken up by Hb) or Helium can be used in this measurement.
239
Using the carbon monoxide gas transfer measurement, one can calculate:
- TLCO (mmol/min/kPa)- total gas exchange capacity
- VA- alveolar volume= number of contributing lung units
- KCO- efficiency of gas transfer per unit of lung
240
TLCO and KCO in normal , extrapulmonary and intrapulmonary disease
In a healthy person: TLCO and KCO will be normal
In extrapulmonary disease: TLCO is low (lungs are smaller) and KCO is high (alveoli are normal and tighly packed with blood vessels
In intrapulmonary disease: TLCO is low (lungs are smaller) and KCO is low (alveoli are abnormal)
241
nasal cavity function
- Nasal cavity warms, humidifies and cleans inspired air thereby protecting respiratory surface from dehydration, temperature changes and pathogens
242
asthma rescue treatment
Hypoxia (poor gas exchange)
- Oxygen
Bronchoconstriction
- B2 agonists eg. salbutamol
• Bronchodilator that may rapidly reduce airway obstruction
• But not 100% specific so risk of activating b1 receptors in the heart (increased heart rate) and b2 receptors in the muscles (tremor)
• Inhaled medication preferred as reduces systemic effects
Airways Inflammation
- Corticosteroids eg. Prednisolone orally, hydrocortisone IV
• Used to stabilise severe attacks by reducing airway inflammation
• Effect takes a few hours to become apparent
243
presentations of COPD
- Chronic bronchitis: cough producing sputum most days for 3 months over 2 consecutive years
- Emphysema: enlarged airspaces distal to terminal bronchioles
- Bronchiolitis: fibrosis and inflammation of small airways
244
signs of COPD
- Resting RR >20 breaths/min
- Accessory muscle use
- Pursed lipped breathing
245
Pharmacological and surgical management of COPD
Pharmacological:
- Oxygen
- Bronchodilators (e.g. b2 agonists, antimuscarinic, theophyllines)
- Corticosteroids (prednisolones)
- Antibiotics
Surgical
- Bullectomy (removal of bulla- dilated air space in parenchyma), transplant
246
short and long acting b2 agonists
Short acting b2 agonists: salbutamol
| Long acting: salmeterol
247
salbutamol: actions, indications, AE
Main actions: act as an agonist at b2 receptors to increase cyclic AMP, smooth muscle relaxation and bronchodilatation
Indications:
- Low dose inhaled: as require or prophylactic
- High dose nebulised: asthma/COPD exacerbations
- Other uses: hyperkalaemia
Adverse effects: tremor, tachycardia & palpitations, hypokalaemia
248
cholinergic receptors
```
Cholinergic receptors (M1, M2, M3) are located in the airways
- Acetylcholine is the neurotransmitter released from postganglionic neurones in the vagus nerve tending
```
249
cholinergic receptor agonists and antagonists
Cholinergic agonists cause:
Smooth muscle to contract → airway narrowing
Submucosal glands to secrete mucus
Cholinergic antagonists cause:
Bronchodilatation
Reduced mucus production
Also inhibits PNS impulses by selectively blocking M2 receptors. Decreases spasms.
250
short and long acting cholinergic antagonists
Short acting: ipratropium bromide
| Long acting: tiotropium
251
Anticholinergic Adverse Effects:
Reduced secretion = dry mouth, throat
Reduced SM contraction = urinary retention, constipation
Reduced vagal tone = headaches, nausea
252
how can systemic adverse effects of respiratory drugs can be significantly reduced?
if they are inhaled into the lungs rather than administered by mouth
253
anticholinergic indications
Indications: COPD, bronchial asthma, rhinitis (inflammation of inside of nose)
254
drugs where monitoring plasma concentration is useful
theophylline, digoxin, phenytoin, gentamicin
255
xanthines: actions, indications, AE
Main actions:
- Phosphodiesterase inhibitor → increase cAMP → PKA activation, TNFa inhibitor and inhibition of leukotriene synthesis
- Bronchodilation
Indications: mainly COPD, asthma rarely
Adverse Effects: tachycardia, palpitations, nausea
256
xanthine drugs
oral: theophylline
IV: aminophylline
257
Leukotriene antagonists e.g. monteleukast: action, indications, AE
Action: Reduces airway narrowing and mucous production usually caused by leukotrienes
Indications: treatment of exercise induced asthma, seasonal allergic rhinitis
AE: abdominal pain, thirst, headache, hyperkinesia, hypersensitivity (vasculitis), increased infection risk, muscle aches, liver damage
258
different routes of corticosteroids
Inhaled: beclometasone
Oral: prednisolone
IV: hydrocortisone
259
Mast Cell Stabilisers e.g. cromoglicate
Action: Stabilises mast cells and reduces release of histamine, prevents airway inflammation
Indications: prophylaxis of asthma, conjunctivitis, allergic rhinitis
Side effects: local irritation (cough), transient bronchospasm
260
adverse effects of oxygen delivery
- Respiratory depression in COPD because when hypoventilation and CO2 retention is prolonged the brain adjusts and is no longer sensitive to CO2 as a drive to breathe
- Patients who then rely on hypoxia as the drive to breath may stop breathing if exposed to too much oxygen
261
Drugs that cause bronchospasm
- Beta-adrenoreceptor antagonists eg. propranolol, atenolol
| - Non-steroidal anti-inflammatory drugs (NSAID)
262
NSAID Induced Bronchospasm
Arachidonic acid released from phospholipids is a precursor to prostaglandins which cause inflammation. Blocking this pathway means that the arachidonic acid is push to the other pathway to produce leukotrienes → cause bronchospasm
263
Drugs that supress respiration
- Opioids eg. morphine
| - Benzodiazepines eg. diazepam
264
Drugs that cause interstitial lung disease (fibrosis)
- Amiodarone
265
pros and cons of inhalation as a route of administration
Advantage –delivers drug directly to the lung, minimises side effects to other parts of the body.
Disadvantage –difficulty in ‘timing’ of delivery of the drug, i.e. using an inhaler effectively, can end up depositing most of drug on back of throat rather than inhaling properly. Can use 'spacers' to increase ease of use of inhaler
266
TB treatment
Rifampicin
- Metabolised by liver, induces cytochrome p450
- Discolours body fluids orange, rash, hepatitis
Isonazide
- Metabolised by liver, enzyme inhibitor
- Hepatitis, rash
Pyridoxine (Vitamin B6) when patients are given Isonazide
- To reduce peripheral neurological effects
Pyrazinamide
- Metabolised by liver
- Hepatitis, rash, arthralgia, gout
Ethambutol
- Metabolised by kidneys, ½ dose if chronic renal failure
- Retrobulbar neuritis
267
TB course
all of RIPE typically for 2 months, then Rifampicin and Isoniazide for 4 more months
268
HBsAg=
surface antigen of Hep B
269
Cor pulmonale
describes structural changes to the right side of the heart due to pulmonary disease. The most frequent mechanism is pulmonary hypertension, which is in turn most commonly caused by COPD
270
factors that cause right shift on O2 saturation curve
increase in:
- temperature
- [H+]
- [CO2]
- 2-3 DPG
271
factors that cause left shift on O2 saturation curve
carbon monoxide
